Noked Capital »

Vaneck Vectors Pharmaceutical etf shares owned by Noked Capital

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Noked Capital from 13F filings

Historical chart of Noked Capital investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Noked Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Noked Capital

Quarter filed Position value Share count Share price at filing
2022-09-30 $9.4M 140k 67.24
2022-06-30 $11M 140k 76.84

More positions owned by Noked Capital

Farfetch Note 3.750% 5/0
Verint Systems Note 0.250% 4/1 Added
Inmode SHS (INMD)
Apple (AAPL)
Microsoft Corporation (MSFT)
4068594 Enphase Energy (ENPH)
Palo Alto Networks (PANW)
Solaredge Technologies (SEDG)
Monday SHS (MNDY)
Nice Sponsored Adr (NICE)
Wix SHS (WIX)
Spdr Ser Tr S&p Biotech (XBI)
Amazon (AMZN)
Invesco Exch Traded Fd Tr Ii Solar Etf (TAN)
Squarespace Class A (SQSP)

View all positions for Noked Capital

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Jpmorgan Chase & Co
Miller Investment Management
Prime Capital Investment Advisors
Independent Advisor Alliance
Phoenix Holdings
Citadel Advisors
Avestar Capital
Gladstone Institutional Advisory
Hrt Financial
Twelve Points Wealth Management
Bank Hapoalim Bm

View all funds holding Vaneck Vectors Pharmaceutical etf